Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2011-01-11
2011-01-11
Bristol, Lynn (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S138100, C424S178100, C436S501000, C530S387100, C530S391300, C530S391700
Reexamination Certificate
active
07867493
ABSTRACT:
PRLR-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.
REFERENCES:
patent: 2004/003019 (2004-01-01), None
MacCallum et al. (J. Mol. Biol. (1996) 262:732-745).
De Pascalis et al. The Journal of Immunology (2002) 169, 3076-3084.
Casset et al. (2003) BBRC 307, 198-205.
Vajdos et al. (2002) J. Mol. Biol. 320, 415-428.
Holm et al (2007) Mol. Immunol. 44: 1075-1084.
Chen et al. J. Mol. Bio. (1999) 293, 865-881.
Wu et al. J. Mol. Biol. (1999) 294, 151-162.
Brummell et al. (Biochemistry 32:1180-1187 (1993)).
Kobayashi et al. (Protein Engineering 12:879-844 (1999)).
Burks et al. (PNAS 94:412-417 (1997)).
Jang et al. (Molec. Immunol. 35:1207-1217 (1998)).
Brorson et al. (J. Immunol. 163:6694-6701 (1999)).
Coleman (Research in Immunol. 145:33-36 (1994)).
Ward et al. (Nature 341:544-546 (1989)).
Smith-Gill et al. (J. Immunol. 139:4135-4144 (1987)).
Kumar et al. (J. Biol. Chem. 275:35129-35136 (2000)).
Song et al. (Biochem Biophys Res Comm 268:390-394 (2000)).
Salfeld (Nature Biotech. 25(12): 1369-1372 (2007)).
Dall'Acqua (J. Immunol. 177:1129-1138 (2006)).
Voskoglou-Nomikos (Clin. Can. Res. 9:4227-4239 (2003)).
Dennis (Nature 442:739-741 (2006)).
Cespdes et al. (Clin. Transl. Oncol. 8(5):318-329 (2006)).
Talmadge et al. (Am. J. Pathol 170(3):793-804 (2007)).
Fujimori et al. (J. Nuc. Med. 31:1191-1198 (1990)).
Beckman et al. (Can. 109:170-179 (2007)).
Thurber et al. (Adv. Drug Deliv. Rev. 60:1421-1434 (2008)).
Rudnick et al. (Can. Biotherp. & Radiopharm. 24: 155-162 (2009)).
Kline et al. (J. Biol. Chem. Jul. 6, 2001; 276(27):24760-6. Epub May 3, 2001).
Santos et al. (Gen. Comp. Endocrinol. Jan. 2001;121(1):32-47; Abstract).
Bedinger Daniel
Damiano Jason
Luqman Mohammad
Masat Linda
Mirza Amer
Bristol Lynn
Marshall & Gerstein & Borun LLP
Novartis AG
XOMA Technology Ltd.
LandOfFree
PRLR-specific antibody and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRLR-specific antibody and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRLR-specific antibody and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619665